- NIR light-controlled mitochondria-targeted delivery of carbon monoxide combined with histone deacetylase inhibition for synergistic anticancer therapy
Qi Tang et al, 2022, Journal of Inorganic Biochemistry CrossRef - Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel
Qi Nie et al, 2023, Molecular Medicine Reports CrossRef - Interactions of Histone Deacetylase 6 with DNA Damage Repair Factors Strengthen its Utility as a Combination Drug Target in High-Grade Serous Ovarian Cancer
Jolene M. Duda et al, 2023, ACS Pharmacology & Translational Science CrossRef - Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
Husvinee Sundaramurthi et al, 2022, International Journal of Molecular Sciences CrossRef - Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
Hanieh Meteran et al, 2024, Journal of Clinical Medicine CrossRef - Differential histone deacetylase inhibitor‐induced perturbations of the global proteome landscape in the setting of high‐grade serous ovarian cancer
Jolene M. Duda et al, 2023, PROTEOMICS CrossRef - HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability
Hong-Ying Dai et al, 2023, Neoplasia CrossRef - HDAC8-Selective Inhibition by PCI-34051 Enhances the Anticancer Effects of ACY-241 in Ovarian Cancer Cells
Ji Yoon Kim et al, 2022, International Journal of Molecular Sciences CrossRef - Structural characterization of fungus-specific histone deacetylase Hos3 provides insights into developing selective inhibitors with antifungal activity
Ningning Pang et al, 2022, Journal of Biological Chemistry CrossRef - Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions
Ghulam Mustafa et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy
Seong-Jun Park et al, 2021, Archives of Pharmacal Research CrossRef - Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
Fengyi Guo et al, 2022, Frontiers in Oncology CrossRef - CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms
Yuanpei Wang et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef - Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy
Muhammad Shahab et al, 2023, Scientific Reports CrossRef - Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
Milan Beljkas et al, 2023, Pharmaceutics CrossRef - HDAC6: A unique HDAC family member as a cancer target
Sumeet Kaur et al, 2022, Cellular Oncology CrossRef